Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989741343> ?p ?o ?g. }
- W2989741343 endingPage "122" @default.
- W2989741343 startingPage "116" @default.
- W2989741343 abstract "Estradiol-17<i>β</i>-glucuronide (E<sub>2</sub>17G) is an estrogen metabolite that has cholestatic properties. In humans, circulating E<sub>2</sub>17G is transported into hepatocytes by organic anion transporting polypeptides (OATPs) and is excreted into bile by multidrug-resistance associated protein 2 (MRP2). E<sub>2</sub>17G is also a substrate of the basolateral efflux transporters MRP3 and MRP4, which translocate E<sub>2</sub>17G from hepatocytes to blood. However, the contribution of basolateral efflux to hepatocyte disposition of E<sub>2</sub>17G has not been evaluated previously. To address this question, E<sub>2</sub>17G disposition was studied in sandwich-cultured human hepatocytes and mechanistic modeling was applied to calculate clearance values (mean ± S.D.) for uptake, intrinsic biliary excretion (CL<sub>int,bile</sub>) and intrinsic basolateral efflux (CL<sub>int,BL</sub>). The biliary excretion index of E<sub>2</sub>17G was 45% ± 6%. The CL<sub>int,BL</sub> of E<sub>2</sub>17G [0.18 ± 0.03 (ml/min)/g liver) was 1.6-fold higher than CL<sub>int,bile</sub> [0.11 ± 0.06 (ml/min)/g liver]. Simulations were performed to study the effects of increased CL<sub>int,BL</sub> and a concomitant decrease in CL<sub>int,bile</sub> on hepatic E<sub>2</sub>17G exposure. Results demonstrated that increased CL<sub>int,BL</sub> can effectively reduce hepatocellular and biliary exposure to this potent cholestatic agent. Simulations also revealed that basolateral efflux can compensate for impaired biliary excretion and, vice versa, to avoid accumulation of E<sub>2</sub>17G in hepatocytes. However, when both clearance processes are impaired by 90%, hepatocyte E<sub>2</sub>17G exposure increases up to 10-fold. These data highlight the contribution of basolateral efflux transport, in addition to MRP2-mediated biliary excretion, to E<sub>2</sub>17G disposition in human hepatocytes. This elimination route could be important, especially in cases where basolateral efflux is induced, such as cholestasis. <h3>SIGNIFICANCE STATEMENT</h3> The disposition of the cholestatic estrogen metabolite estradiol-17β-glucuronide (E<sub>2</sub>17G) was characterized in sandwich-cultured human hepatocytes. The intrinsic basolateral efflux clearance was estimated to be 1.6-fold higher than the intrinsic biliary excretion clearance, emphasizing the contribution of basolateral elimination in addition to biliary excretion. Simulations highlight how hepatocytes can effectively cope with increased E<sub>2</sub>17G through the regulation of both basolateral and biliary transporters." @default.
- W2989741343 created "2019-12-05" @default.
- W2989741343 creator A5003083510 @default.
- W2989741343 creator A5078062064 @default.
- W2989741343 creator A5090830617 @default.
- W2989741343 date "2019-11-19" @default.
- W2989741343 modified "2023-10-09" @default.
- W2989741343 title "Mechanistic Modeling of the Hepatic Disposition of Estradiol-17<i>β</i>-Glucuronide in Sandwich-Cultured Human Hepatocytes" @default.
- W2989741343 cites W1497240742 @default.
- W2989741343 cites W1782326413 @default.
- W2989741343 cites W1966431705 @default.
- W2989741343 cites W1969152071 @default.
- W2989741343 cites W1975742715 @default.
- W2989741343 cites W1985418355 @default.
- W2989741343 cites W1987161483 @default.
- W2989741343 cites W1991359947 @default.
- W2989741343 cites W1997696660 @default.
- W2989741343 cites W1998201688 @default.
- W2989741343 cites W1999715603 @default.
- W2989741343 cites W2000992901 @default.
- W2989741343 cites W2004389502 @default.
- W2989741343 cites W2010448327 @default.
- W2989741343 cites W2027665912 @default.
- W2989741343 cites W2028337644 @default.
- W2989741343 cites W2028908767 @default.
- W2989741343 cites W2042948144 @default.
- W2989741343 cites W2044459219 @default.
- W2989741343 cites W2050007442 @default.
- W2989741343 cites W2053706150 @default.
- W2989741343 cites W2068097474 @default.
- W2989741343 cites W2068678447 @default.
- W2989741343 cites W2074274895 @default.
- W2989741343 cites W2081048081 @default.
- W2989741343 cites W2099887778 @default.
- W2989741343 cites W2104270120 @default.
- W2989741343 cites W2107790148 @default.
- W2989741343 cites W2113222839 @default.
- W2989741343 cites W2138139209 @default.
- W2989741343 cites W2139825215 @default.
- W2989741343 cites W2144948193 @default.
- W2989741343 cites W2147909274 @default.
- W2989741343 cites W2148587422 @default.
- W2989741343 cites W2152548885 @default.
- W2989741343 cites W2157772258 @default.
- W2989741343 cites W2161224665 @default.
- W2989741343 cites W2164424203 @default.
- W2989741343 cites W2608581123 @default.
- W2989741343 cites W2776265394 @default.
- W2989741343 cites W2786949495 @default.
- W2989741343 cites W2794426451 @default.
- W2989741343 cites W2888742389 @default.
- W2989741343 cites W2906355594 @default.
- W2989741343 cites W2909357224 @default.
- W2989741343 cites W4246191544 @default.
- W2989741343 doi "https://doi.org/10.1124/dmd.119.088898" @default.
- W2989741343 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6978695" @default.
- W2989741343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31744810" @default.
- W2989741343 hasPublicationYear "2019" @default.
- W2989741343 type Work @default.
- W2989741343 sameAs 2989741343 @default.
- W2989741343 citedByCount "2" @default.
- W2989741343 countsByYear W29897413432021 @default.
- W2989741343 countsByYear W29897413432022 @default.
- W2989741343 crossrefType "journal-article" @default.
- W2989741343 hasAuthorship W2989741343A5003083510 @default.
- W2989741343 hasAuthorship W2989741343A5078062064 @default.
- W2989741343 hasAuthorship W2989741343A5090830617 @default.
- W2989741343 hasBestOaLocation W29897413431 @default.
- W2989741343 hasConcept C10146269 @default.
- W2989741343 hasConcept C104317684 @default.
- W2989741343 hasConcept C126322002 @default.
- W2989741343 hasConcept C133936738 @default.
- W2989741343 hasConcept C134018914 @default.
- W2989741343 hasConcept C149011108 @default.
- W2989741343 hasConcept C185592680 @default.
- W2989741343 hasConcept C200082930 @default.
- W2989741343 hasConcept C202751555 @default.
- W2989741343 hasConcept C2776200302 @default.
- W2989741343 hasConcept C2776678969 @default.
- W2989741343 hasConcept C2777164284 @default.
- W2989741343 hasConcept C2777477808 @default.
- W2989741343 hasConcept C2778707650 @default.
- W2989741343 hasConcept C36201501 @default.
- W2989741343 hasConcept C44312359 @default.
- W2989741343 hasConcept C501593827 @default.
- W2989741343 hasConcept C55493867 @default.
- W2989741343 hasConcept C71924100 @default.
- W2989741343 hasConcept C86803240 @default.
- W2989741343 hasConceptScore W2989741343C10146269 @default.
- W2989741343 hasConceptScore W2989741343C104317684 @default.
- W2989741343 hasConceptScore W2989741343C126322002 @default.
- W2989741343 hasConceptScore W2989741343C133936738 @default.
- W2989741343 hasConceptScore W2989741343C134018914 @default.
- W2989741343 hasConceptScore W2989741343C149011108 @default.
- W2989741343 hasConceptScore W2989741343C185592680 @default.
- W2989741343 hasConceptScore W2989741343C200082930 @default.
- W2989741343 hasConceptScore W2989741343C202751555 @default.
- W2989741343 hasConceptScore W2989741343C2776200302 @default.